Bharat Immunological & Biological Corporation Ltd Q2 FY2023-2024 Results: Summary
Revenue | ₹0.16Cr |
Net Profits | ₹-4.92Cr |
Net Profit Margins | -3075% |
Highlights
Bharat Immunological & Biological Corporation Ltd’s revenue fell -99.4% since last year same period to ₹0.16Cr in the Q2 2023-2024. On a quarterly growth basis, Bharat Immunological & Biological Corporation Ltd has generated 60% jump in its revenue since last 3-months.
Bharat Immunological & Biological Corporation Ltd’s net profit fell -59.74% since last year same period to ₹-4.92Cr in the Q2 2023-2024. On a quarterly growth basis, Bharat Immunological & Biological Corporation Ltd has generated -7.19% fall in its net profits since last 3-months.
Bharat Immunological & Biological Corporation Ltd’s net profit margin fell -26656.49% since last year same period to -3075% in the Q2 2023-2024. On a quarterly growth basis, Bharat Immunological & Biological Corporation Ltd has generated 33.01% jump in its net profit margins since last 3-months.
